Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 0.38 USD 4.45% Market Closed
Market Cap: 53.8m USD

Wall Street
Price Targets

APLT Price Targets Summary
Applied Therapeutics Inc

Wall Street analysts forecast APLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APLT is 2.93 USD with a low forecast of 1.52 USD and a high forecast of 5.25 USD.

Lowest
Price Target
1.52 USD
299% Upside
Average
Price Target
2.93 USD
672% Upside
Highest
Price Target
5.25 USD
1 282% Upside
Applied Therapeutics Inc Competitors:
Price Targets
4893
Noile-Immune Biotech Inc
174% Upside
OSE
OSE Immunotherapeutics SA
178% Upside
301207
Hualan Biological Bacterin Inc
17% Upside
FHTX
Foghorn Therapeutics Inc.
162% Upside
688278
Xiamen Amoytop Biotech Co Ltd
36% Upside
PRTC
PureTech Health PLC
253% Upside
251120
Bio-FD&C Co Ltd
17% Upside

Revenue
Forecast

Revenue Estimate
Applied Therapeutics Inc

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 3 years is 391%.

N/A
Past Growth
391%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Applied Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Applied Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-80%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APLT's stock price target?
Price Target
2.93 USD

According to Wall Street analysts, the average 1-year price target for APLT is 2.93 USD with a low forecast of 1.52 USD and a high forecast of 5.25 USD.

What is Applied Therapeutics Inc's Revenue forecast?
Projected CAGR
391%

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 3 years is 391%.

Back to Top